Are you Dr. Bristow?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4200 E 9th Ave
Denver, CO 80262Phone+1 303-493-7000
Summary
- Dr. Michael Bristow, MD is a cardiologist in Denver, Colorado. He is currently licensed to practice medicine in Colorado, Utah, and California. He is affiliated with University of Colorado Hospital and is a Professor at University of Colorado School of Medicine.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1977 - 1979
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1976 - 1977
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1971 - 1972
- University of Illinois College of MedicineClass of 1970
Certifications & Licensure
- CA State Medical License 1973 - Present
- CO State Medical License 1991 - 2025
- UT State Medical License 1984 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1985
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart Start of enrollment: 2000 Sep 01
- Pulse Reduction On Beta-blocker and Ivabradine Therapy Start of enrollment: 2016 Nov 01
Publications & Presentations
PubMed
- Dose Limiting, Adverse Event Associated Bradycardia with β-blocker Treatment of Atrial Fibrillation in the GENETIC-AF TrialWilliam T. Abraham, Jonathan P. Piccini, Christopher Dufton, Ian A. Carroll, Jeff S. Healey
Heart Rhythm O2. 2021-11-12 - 1017 citationsCarvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureMichael R. Bristow, Edward M. Gilbert, William T. Abraham, Kirkwood F. Adams, Michael B. Fowler
Circulation. 1996-12-01 - 194 citationsMechanism of Action of Beta-Blocking Agents in Heart FailureMichael R. Bristow
The American Journal of Cardiology. 1997-12-04
Authored Content
- Dynamic Regulation of SARS-CoV-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular MyocardiumJune 2020
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure — NEJMMay 1996
Press Mentions
- A CU Cardiology Leader for 28 Years Is Honored by Global Peers and FamilySeptember 17th, 2024
- Heart Failure Strategically Focused Research Network: Summary of Results and Future DirectionsSeptember 8th, 2022
- Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory BoardFebruary 24th, 2020
- Join now to see all
Grant Support
- Beta-Blocker Effect On Remodeling And Gene ExpressionNational Center For Research Resources2004–2008
- Genetic-Adrenergic Interactions In Myocardial FailureNational Heart, Lung, And Blood Institute2004–2007
- Dynamic Expression Profiling In The Intact Human HeartNational Heart, Lung, And Blood Institute2002–2003
- Altered Gene Expression In The Failing Human HeartNational Heart, Lung, And Blood Institute1999–2003
- Effects Of Chronic Trtmnt WI Bucindolol HCL Or Metoprolol TartrateNational Center For Research Resources1999–2002
- Contractile Protein Expression In Failing Human HeartNational Heart, Lung, And Blood Institute1998–2002
- Beta Adrenergic Blockade In Patients With Congestive Heart FailureNational Center For Research Resources1996–2002
- Parallel, Dose RESP Study--Sustnd Released Moxonidine In CHF PatientsNational Center For Research Resources1999–2000
- Efficacy Of IV Milrinone In Patients With Congestive Heart FailureNational Center For Research Resources1998–2000
- Postgraduate Training In Cardiovascular ResearchNational Heart, Lung, And Blood Institute1996–2000
- Adrenergic Mechanisms In The Intact Failing Human HeartNational Heart, Lung, And Blood Institute1993–1996
- Therapy With And Withdrawal Of Beta Adrenergic Blockade In PT W Conge Heart FailNational Center For Research Resources1995
- OPC 18790 In Subjects With Heart FailureNational Center For Research Resources1993–1995
- A Dose Range Finding Study Of Intravenous 349u85 HCL In Congestive Heart FailureNational Center For Research Resources1993–1995
Professional Memberships
- Member